Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: E'Lane who wrote (9071)	6/3/1998 10:06:00 PM
From: VLAD	Respond to of 23519

E'Lane, A few honest doctors and one good lawfirm is all it will take now to allow truth to prevail. The CNBC hype will not save Pfizer nor will the FDA. The sadest part of the matter is that in America big money and big profit take priority over safety issues. Taking a pill to create a new stud is such a wonderful idea that the public will have to pay the costs in lives lost. The only thing that Pfizer understands is $$$$$. So when the lawyers start asking for big $$$$$$$$$$$$$ to compensate for loss of life, I am sure that it will be a message well understood. If you remember I posted a report 2 days ago about a relatively healthy Chicago area man dying after taking Viagra. According to the news report the family was very upset and planning legal action. E'Lane, the media and public are still in the honeymoon stage of Viagra at the cost of Vivus. After the latest reports on Viagra associated deaths I think that the honeymoon may very well be coming to an end. It is sad that Vivus shareholders have to see men die on Viagra in order to give significance to MUSE.